Achilles Therapeutics Plc., a clinical-stagr biopharmaceutical company developing precision T cell therapies to treat various solid tumors (cancer). It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. Achilles was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in 2021/02. The company was founded in 2016 and is headquartered in London, UK.
What is Achilles Therapeutics's quote symbol?
What is the 52 week high and low for Achilles Therapeutics (NASDAQ: ACHL)?
How much is Achilles Therapeutics stock worth today?
How much is Achilles Therapeutics's stock price per share?
What is Achilles Therapeutics's Market Cap?